SCHEMBL6509586

SCHEMBL6509586

COc1ccc(S(=O)(=O)N(C)c2ccc3oc(C(=O)NO)cc3c2)cc1OC

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.44
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.43
NAMPT P43490 2/20 0.41
USP2 O75604 1/20 0.41
PTPN22 Q9Y2R2 1/20 0.41
BCAT1 P54687 1/20 0.41
MAPT P10636 3/20 0.41
ALDH1A1 P00352 3/20 0.41
OPRM1 P35372 1/20 0.41
TMEM97 Q5BJF2 1/20 0.41
SIGMAR1 Q99720 1/20 0.41
HPGD P15428 1/20 0.41
LMNA P02545 2/20 0.41
NPC1 O15118 1/20 0.41
CLK1 P49759 1/20 0.41
NR2F2 P24468 1/20 0.40
TSHR P16473 1/20 0.39
GAA P10253 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6510460 0.83 PTPN22 (0.50) RAB9AKMT2APTPN22BCAT1MAPT
SCHEMBL6509270 0.83 BCAT1 (0.50) RAB9AKMT2AMEN1PTPN22BCAT1
SCHEMBL6509960 0.81 PTPN22 (0.58) RAB9AKMT2AMEN1PTPN22MAPT
SCHEMBL15482236 0.79 MAPT (0.57) RAB9AUSP2MAPTALDH1A1HPGD
SCHEMBL6509584 0.79 MEN1 (0.48) RAB9AKMT2AMEN1L3MBTL1NAMPT
SCHEMBL6510386 0.78 HDAC1 (0.47) RAB9ANAMPTMAPTALDH1A1HPGD
SCHEMBL15480595 0.70 KDM4E (0.48) USP2MAPTALDH1A1HPGDLMNA
SCHEMBL6038344 0.68 NR1H2 (0.56) RAB9AKMT2AMAPTALDH1A1LMNA
SCHEMBL6507327 0.67 ALDH1A1 (0.42) RAB9AKMT2AMEN1BCAT1MAPT
SCHEMBL9049128 0.66 SIRT2 (0.47) KMT2AMAPTHPGDLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005066151-A2 HISTONE DEACETYLASE INHIBITORS TAKEDA SAN DIEGO, INC. (US) 2005-07-21 WO claimed
US-20050137234-A1 Histone deacetylase inhibitors SYRRX, INC. 2005-06-23 US claimed
WO-2005066151-A2 HISTONE DEACETYLASE INHIBITORS TAKEDA SAN DIEGO, INC. (US) 2005-07-21 WO disclosed
US-20050137234-A1 Histone deacetylase inhibitors SYRRX, INC. 2005-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050137234-A1 Histone deacetylase inhibitors HDAC1, HDAC5, HDAC11 RAB9A 3382/4885KMT2A 45/4885MEN1 2925/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.